Similar to intratumoral Tregs isolated from tissue biopsy specimens from B-cell non-Hodgkin lymphoma patients [49], in our study, Tregs from DLBCL patients displayed an enhanced ability to suppress CD8+ CTLs. Here, CD8A is linked to B-cell non-Hodgkin lymphoma.